Cicletanine Therapy Is Well Tolerated in Patients with Advanced Pulmonary Arterial Hypertension (PAH)

被引：0
|
作者：
Waxman, A. B. [1 ,2 ]
Lawler, L. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3353
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of Riociguat on Pulmonary Arterial Compliance in Patients With Pulmonary Arterial Hypertension (PAH) in the Respite Study
    Thenappan, Thenappan
    Hoeper, Marius
    Corris, Paul
    Ghofrani, Hossein-Ardeschir
    Klinger, James
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond
    CHEST, 2017, 152 (04) : 1005A - 1006A
  • [22] Prevalence of Pulmonary Arterial Hypertension (PAH) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
    Villar, Adolfo
    Ancochea, Julio
    Xaubet, Antonio
    CHEST, 2014, 145 (03)
  • [23] A Literature Review of Pulmonary Arterial Hypertension (PAH)
    Panchal, Ashima
    Panchal, Jigar
    Jain, Sonika
    Dwivedi, Jaya
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2022, 18 (02) : 104 - 114
  • [24] Endothelial dysfunction in pulmonary arterial hypertension (PAH)
    Thambiayya, Kalidasan
    FASEB JOURNAL, 2015, 29
  • [25] Safety and efficacy of sitaxsentan in elderly patients with Pulmonary Arterial Hypertension (PAH)
    Vachiery, J. L.
    Sandoval-Zarate, J.
    Keogh, A.
    Kramer, M. R.
    Barst, R. J.
    Naeije, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 623 - 623
  • [26] Left Ventricular Diastolic Dysfunction in Patients With Pulmonary Arterial Hypertension (PAH)
    Dadfarmay, Sina
    Alhaj, Eyad
    Manchikalapudi, Rama Bindu
    Satya, Kumar
    Berkowitz, Robert
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S19 - S19
  • [27] Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
    Escribano, P.
    Gaine, S.
    Biedermann, P.
    Muller, A.
    Valge, M.
    Lange, T.
    Soderberg, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S109 - S109
  • [28] Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)
    Dubrock, Hilary M.
    Germack, Hayley D.
    Gauthier-Loiselle, Marjolaine
    Linder, Joerg
    Satija, Ambika
    Manceur, Ameur M.
    Cloutier, Martin
    Lefebvre, Patrick
    Panjabi, Sumeet
    Frantz, Robert P.
    PHARMACOECONOMICS-OPEN, 2024, 8 (01) : 133 - 146
  • [29] The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
    Sikirica, Mirko
    Iorga, Serban R.
    Bancroft, Tim
    Potash, Jesse
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [30] Hemodynamic effects of sildenafil citrate in patients with pulmonary arterial hypertension (PAH)
    Rubin, L
    Burgess, G
    Parpia, T
    Burst, R
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 93A - 94A
12345